Mission Statement:
The mission of the National Neurovision Research Institute (NNRI) is to accelerate the translation of laboratory based research into clinical trials for treatments and cures of retinal degenerative diseases.

Background of NNRI:
NNRI is a newly established non-profit entity, a support organization of the Foundation Fighting Blindness (FFB). The mission of the NNRI is to accelerate the translation of laboratory based research into clinical trials for treatments and cures of retinal degenerative diseases. It is a medical research institute that will obtain support from government agencies, corporations and private foundations. It may also receive royalties or licensing fees from the drug discovery processes and commercialization of new therapies.

The FFB is a non-profit health foundation that has been incorporated since 1971. Over the years FFB has invested over 140 million dollars to provide seed money for scientific research of diseases of the retina causing blindness.

Goals of NNRI:
The goal of NNRI is to develop a bridge between scientific, clinical, governmental, pharmaceutical and financial communities to advance clinical trials of candidate pharmaceutical and genetic therapies and delivery systems for orphan retinal degenerative diseases (RDD’s). In this regard, NNRI wishes to educate the scientific and clinical communities of opportunities and processes of drug discovery.

As a medical research institute, NNRI will search for candidate therapies and explore new pathogenetic pathways of retinal diseases to further the drug discovery process.

NNRI will raise funds to support Phase I and Phase II clinical trials in order to expedite the commercialization of candidate therapies for RDD patients. NNRI will also provide assistance to the management of clinical trials and subsequent commercialization.

Executive Summary of Symposium